Showing 51–75 of 133 international scientific journals (Immunology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Clinical Immunology ISSN: 1521-6616 / 1521-7035 | 🇺🇸United States | Q2 | CAS Tier 3 | 4.1 | 1.317Q2 | 112 | 145 | 2.2% | Academic Press Inc. | Profile |
| 52 | European Journal of Immunology ISSN: 0014-2980 / 1521-4141 | 🇺🇸United States | Q2 | CAS Tier 3 | 4.1 | 1.666Q1 | 187 | 189 | 4.4% | Wiley-VCH Verlag | Profile |
| 53 | ImmunoTargets and Therapy ISSN: 2253-1556Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 4.1 | 1.11Q2 | — | 30 | 0% | Dove Medical Press | Profile |
| 54 | Journal of Clinical Immunology ISSN: 0271-9142 / 1573-2592 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.1 | 1.802Q1 | 87 | 131 | 6.9% | Springer US | Profile |
| 55 | Expert Review of Clinical Immunology ISSN: 1744-666X / 1744-8409 | 🇺🇸United States | Q2 | CAS Tier 3 | 4 | 1.198Q2 | 42 | 104 | 0% | Taylor and Francis Ltd. | Profile |
| 56 | Journal of Immunology ISSN: 0022-1767 / 1550-6606 | 🇺🇸United States | Q2 | CAS Tier 3 | 4 | 1.444Q1 | 345 | 555 | 2.8% | American Association of Immunologists | Profile |
| 57 | World Allergy Organization Journal ISSN: 1939-4551 | 🇳🇱Netherlands | Q2 | CAS Tier 2 | 4 | 1.225Q1 | 29 | 104 | 2.6% | BioMed Central | Profile |
| 58 | Clinical and Experimental Immunology ISSN: 0009-9104 / 1365-2249 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.9 | 1.41Q1 | 125 | 114 | 2.9% | Wiley-Blackwell Publishing Ltd | Profile |
| 59 | Microbial Pathogenesis ISSN: 0882-4010 / 1096-1208 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.9 | 0.936Q2 | 64 | 568 | 3% | Academic Press Inc. | Profile |
| 60 | Journal of Microbiology Immunology and Infection ISSN: 1684-1182 / 1995-9133 | 🌐Taiwan | Q2 | CAS Tier 2 | 3.8 | 1.066Q1 | 48 | 146 | 6.7% | Elsevier Taiwan LLC | Profile |
| 61 | Molecular Immunology ISSN: 0161-5890 / 1872-9142 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.7 | 0.969Q2 | 113 | 294 | 0% | Elsevier Ltd | Profile |
| 62 | Neuroimmunomodulation ISSN: 1021-7401 / 1423-0216 | 🇨🇭Switzerland | Q2 | CAS Tier 3 | 3.7 | 0.801Q2 | 58 | 66 | 4.5% | S. Karger AG | Profile |
| 63 | Cytokine ISSN: 1043-4666 / 1096-0023 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.6 | 1.083Q1 | 103 | 349 | 2.7% | Academic Press Inc. | Profile |
| 64 | Innate Immunity ISSN: 1753-4259 / 1753-4267 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.5 | 0.926Q2 | 63 | 39 | 0% | SAGE Publications Ltd | Profile |
| 65 | Journal of Reproductive Immunology ISSN: 0165-0378 / 1872-7603 | 🇳🇱Netherlands | Q2 | CAS Tier 3 | 3.5 | 0.956Q1 | 79 | 135 | 6.9% | Elsevier Ireland Ltd | Profile |
| 66 | Current Opinion in Hiv and Aids ISSN: 1746-630X | 🇺🇸United States | Q3 | CAS Tier 2 | 3.4 | 1.331Q1 | 53 | 39 | 2.2% | Lippincott Williams and Wilkins Ltd. | Profile |
| 67 | International Immunology ISSN: 0953-8178 / 1460-2377 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.4 | 1.354Q1 | 124 | 90 | 2.1% | Oxford University Press | Profile |
| 68 | Journal of Leukocyte Biology ISSN: 0741-5400 / 1938-3673 | 🇺🇸United States | Q3 | CAS Tier 3 | 3.4 | 1.203Q2 | 175 | 171 | 0% | John Wiley & Sons Inc. | Profile |
| 69 | Vaccine ISSN: 0264-410X / 1358-8745 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.4 | 1.186Q1 | 164 | 926 | 6.7% | Elsevier BV | Profile |
| 70 | Antibodies ISSN: 2073-4468 | 🇨🇭Switzerland | Q3 | CAS Tier 3 | 3.3 | 0.906Q2 | — | 47 | 6.7% | MDPI AG | Profile |
| 71 | Cellular Immunology ISSN: 0008-8749 / 1090-2163 | 🇺🇸United States | Q3 | CAS Tier 3 | 3.3 | 1.034Q2 | 83 | 116 | 2.7% | Academic Press Inc. | Profile |
| 72 | Immunology and Cell Biology ISSN: 0818-9641 / 1440-1711 | 🌐Australia | Q3 | CAS Tier 4 | 3.3 | 1.079Q2 | 96 | 55 | 6.2% | John Wiley & Sons Inc. | Profile |
| 73 | Archivum Immunologiae et Therapiae Experimentalis ISSN: 0004-069X / 1661-4917 | 🌐Poland | Q3 | CAS Tier 3 | 3.2 | 0.759Q2 | 51 | 31 | 3.4% | Springer International Publishing | Profile |
| 74 | Immunology Letters ISSN: 0165-2478 / 1879-0542 | 🇳🇱Netherlands | Q3 | CAS Tier 3 | 3.2 | 1.038Q2 | 85 | 103 | 0% | Elsevier | Profile |
| 75 | Infectious Agents and Cancer ISSN: 1750-9378 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.2 | 0.92Q2 | 30 | 66 | 3.2% | BioMed Central | Profile |